Senex
Edit

Senex

http://senexbio.com/
Last activity: 06.01.2025
Active
Categories: BioTech
Biotechnology
Mentions
5
Employees: 11-50
Founded date: 2002

Investors 1

Mentions in press and media 5

DateTitleDescription
06.01.2025Senex Awarded STTR Grant from National Cancer Institute for CDK8/19 Inhibition as Treatment of Metastatic Ovarian CancerMythreye Karthikeyan, Ph.D. CDK8/19 Mediator kinase in multiple cancers Senex Biotechnology Logo The grant expands the Company’s focus on women’s health following our recent publication on the importance of CDK8/19 inhibition as treatment f...
18.11.2024Senex Publication Reveals Importance of CDK8/19 Inhibition as Treatment for Triple Negative Breast CancerProfessor Eugenia Broude CDK8/19 Mediator Kinase CDK8/19 Mediator kinase in multiple cancers Expression of CDK8/19 Mediator kinase controls transcriptional reprogramming and correlates with relapse-free survival and treatment failure in bre...
07.10.2024Senex Biotechnology Receives Notice of Allowance for Novel CDK8/19 Inhibitors from European Patent OfficeDennis Goldberg, CEO of Senex Biotechnology CDK8/19 Mediator Kinase CDK8/19 Mediator kinase in multiple cancers European Patent Expands Upon Similar Patent Granted by the USPTO The European patent for SNX631-6, combined with the previously ...
18.10.2021Australia's Senex gets $605 million takeover offer from POSCO International, seeks moreThe A$815 million or A$4.40 per share offer from POSCO International, the trading arm of steel giant POSCO, has already been twice-improved, Senex said. "The Senex Board believes it is in the best interests of its shareholders to conti...
18.10.2021Australia's Senex gets $605 mln takeover offer from POSCO International, seeks more* Senex seeks more than A$4.40 a share * POSCO International wants to beef up gas reserves * Senex shares jump 15% to just below offer price MELBOURNE, Oct 18 (Reuters) - Australian coal seam gas producer Senex Energy Ltd said it had receiv...

Reviews 0

Sign up to leave a review

Sign up Log In